Search - tctmd.com

Displaying 21 - 40 of 405

Sort: Relevancy | Date

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News EACTS 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Michael O'Riordan

October 13, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Presentation ESC 2023

Post procedural anticoagulation after primary percutaneous coronary intervention for ST segment elevation myocardial infarction: a multicentre, randomised, double blind trial

Presenter: Shaoping Nie

August 28, 2023

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Todd Neale

May 05, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

Advertisement

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Top Coronary Artery Disease News of 2023

Surgeons Support Proposed Changes to Left Main CAD Guidelines

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Post procedural anticoagulation after primary percutaneous coronary intervention for ST segment elevation myocardial infarction: a multicentre, randomised, double blind trial

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content